The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Body Surface Distribution and Response to Drugs of ST Segment Elevation in Brugada Syndrome: Clinical Implication of Eighty‐Seven–Lead Body Surface Potential Mapping and Its Application to Twelve‐Lead Electrocardiograms
Open accessAbstract
ST Elevation in Brugada Syndrome. Introduction: Body surface distribution and magnitude of ST segment elevation and their reflection in 12‐lead ECGs have not been clarified in Brugada syndrome. Methods and Results: Eighty‐seven‐lead body surface potential mapping and 12‐lead ECGs were recorded simultaneously in 25 patients with Brugada syndrome and 40 control patients. The amplitude of the ST segment 20 msec after the end of QRS (ST20) was measured from all 87 leads, and an ST isopotential map was constructed. The maximum ST elevation (maxST20) was distributed in an area of the right ventricular outflow tract in all Brugada patients, and it was larger than that in control patients (0.37 ± 0.13 vs 0.12 ± 0.04 mV; P < 0.0005). The maximum was observed on the level of the parasternal fourth intercostal space, on which the VI and V2 leads of the standard 12‐lead ECG were located, in 18 of the 25 Brugada patients in whom typical coved‐ or saddleback type ST elevation was seen in leads VI and V2. The maximum was located on the second intercostals space in the remaining seven Brugada patients in whom only a mild saddleback‐type ST elevation was seen in leads V1 and V2 of the 12‐lead ECG. Typical ST segment elevation was recognized in leads V1 and V2, which were recorded on the second or third intercostal space. ST elevation in Brugada patients was dramatically normalized by isoproterenol, a β‐adrenergic agonist (maxST20 = 0.17 ± 0.08 mV; P < 0.0005 vs control conditions), and accentuated by disopyramide, an Na+ channel blocker (maxST20 = 0.50 ± 0.15 mV; P < 0.0005 vs control conditions), without any change in the location of the maxST20. Conclusion: Our data indicate that recordings of leads V1‐V3 of the 12‐lead ECG on the parasternal second or third intercostal space would be helpful in diagnosing suspected patients with Brugada syndrome. The data suggest that Na+ channel blockers are capable of accentuating ST elevation in leads V1‐V3.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Brugada, P., & Brugada, J. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90253-j · Cited by 3,331
Yan, G.-X., & Antzelevitch, C. (1999) · Circulation · doi:10.1161/01.cir.100.15.1660 · Cited by 1,126
Miyazaki, T., Mitamura, H., Miyoshi, S., Soejima, K., Aizawa, Y., & Ogawa, S. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00613-3 · Cited by 764
Brugada, J., Brugada, R., & Brugada, P. (1998) · Circulation · doi:10.1161/01.cir.97.5.457 · Cited by 713
Arrhythmogenic Marker for the Sudden Unexplained Death Syndrome in Thai Men
Nademanee, K., Veerakul, G., Nimmannit, S., Chaowakul, V., Bhuripanyo, K., Likittanasombat, K., Tunsanga, K., Kuasirikul, S., Malasit, P., Tansupasawadikul, S., et al. (1997) · Circulation · doi:10.1161/01.cir.96.8.2595 · Cited by 536
The Brugada syndrome: clinical, electrophysiologic and genetic aspects
Gussak, I., Antzelevitch, C., Bjerregaard, P., Towbin, J., & Chaitman, B. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00528-2 · Cited by 501
Cardiac Electrophysiology: From Cell to Bedside
(2014) · Elsevier eBooks · doi:10.1016/c2011-0-06826-6 · Cited by 435
“Brugada” Syndrome: Clinical Data and Suggested Pathophysiological Mechanism
Alings, M., & Wilde, A. (1999) · Circulation · doi:10.1161/01.cir.99.5.666 · Cited by 422
Kasanuki, H., Ohnishi, S., Ohtuka, M., Matsuda, N., Nirei, T., Isogai, R., Shoda, M., Toyoshima, Y., & Hosoda, S. (1997) · Circulation · doi:10.1161/01.cir.95.9.2277 · Cited by 419
ANTZELEVITCH, C. (1998) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.1998.tb01844.x · Cited by 246
Cited by
Antzelevitch, C., Brugada, P., Borggrefe, M., Brugada, J., Brugada, R., Corrado, D., Gussak, I., LeMarec, H., Nademanee, K., Perez Riera, A. R., et al. (2005) · Circulation · doi:10.1161/01.cir.0000152479.54298.51 · Cited by 1,807
Self-citationProposed Diagnostic Criteria for the Brugada Syndrome: Consensus Report
Wilde, A. A. M., Antzelevitch, C., Borggrefe, M., Brugada, J., Brugada, R., Brugada, P., Corrado, D., Hauer, R. N. W., Kass, R. S., Nademanee, K., et al. (2002) · Circulation · doi:10.1161/01.cir.0000034169.45752.4a · Cited by 827
J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge
Antzelevitch, C., Yan, G.-X., Ackerman, M. J., Borggrefe, M., Corrado, D., Guo, J., Gussak, I., Hasdemir, C., Horie, M., Huikuri, H., et al. (2016) · Heart Rhythm · doi:10.1016/j.hrthm.2016.05.024 · Cited by 621
Self-citationJ-Point Elevation in Survivors of Primary Ventricular Fibrillation and Matched Control Subjects
Rosso, R., Kogan, E., Belhassen, B., Rozovski, U., Scheinman, M. M., Zeltser, D., Halkin, A., Steinvil, A., Heller, K., Glikson, M., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.07.010 · Cited by 566
Antzelevitch, C., & Yan, G.-X. (2010) · Heart Rhythm · doi:10.1016/j.hrthm.2009.12.006 · Cited by 571
Metadata
- Authors
- SHIMIZU, W., MATSUO, K., TAKAGI, M., TANABE, Y., AIBA, T., TAGUCHI, A., SUYAMA, K., KURITA, T., AIHARA, N., & KAMAKURA, S.
- Venue
- Journal of Cardiovascular Electrophysiology
- Publisher
- Wiley
- Published
- 2000-04
- Volume
- 11
- Issue
- 4
- Pages
- 396-404
- ISSN
- 1045-3873 (ISSN-L)
- 1540-8167
- OpenAlex
- W1989115606
- Cited by
- 256
- References
- 19
- FWCI
- 7.99
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Body Surface Distribution and Response to Drugs of ST Segment Elevation in Brugada Syndrome: Clinical Implication of Eighty‐Seven–Lead Body Surface Potential Mapping and Its Application to Twelve‐Lead Electrocardiograms. https://app.cochat.ai/papers/10.1111/j.1540-8167.2000.tb00334.x
- The paper
- SHIMIZU, W., MATSUO, K., TAKAGI, M., TANABE, Y., AIBA, T., TAGUCHI, A., SUYAMA, K., KURITA, T., AIHARA, N., & KAMAKURA, S. (2000). Body Surface Distribution and Response to Drugs of ST Segment Elevation in Brugada Syndrome: Clinical Implication of Eighty‐Seven–Lead Body Surface Potential Mapping and Its Application to Twelve‐Lead Electrocardiograms. Journal of Cardiovascular Electrophysiology. https://doi.org/10.1111/j.1540-8167.2000.tb00334.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.